Dr. Neil Alan Shneider, MD, PhD

Dr. Shneider practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Shneider's NPI, 1477676161, was assigned on April 9, 2007. Dr. Shneider graduated from Columbia University College of Physicians and Surgeons in 1994. Dr. Shneider holds New York license 211181.

Dr. Shneider's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Shneider's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Shneider is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Shneider to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shneider practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shneider's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shneider is licensed in New York.

CMS data shows 238 Medicare services from Dr. Shneider across 8 procedure codes in 2024, for 36 Medicare patients. Medicare paid $19,908 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Dr. Shneider in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shneider's median patient age at 66, with 43% women.

In 2024, Dr. Shneider wrote 217 Medicare Part D claims for 38 patients. 77% of them were for generic drugs. CMS names the drug for 188 of them, across 5 drugs with 11 or more claims each, at $217,543 in total drug cost. In 2023, CMS named 206 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shneider for performance year 2024, reported through an alternative payment model (APM). Dr. Shneider accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shneider as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Shneider, published from 2015 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Amyotrophic Lateral Sclerosis, RNA-Binding Protein FUS and Neurodegenerative Diseases. Dr. Shneider has published most often in Amyotroph Lateral Scler Frontotemporal Degener. Dr. Shneider's most frequent co-authors are Matthew B. Harms, MD, Jinsy Andrews, MD and Michael Benatar, MD.

CMS Open Payments shows 59 general payments to Dr. Shneider from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Sunovion Pharmaceuticals Inc. paid the most, $21,692.

Dr. Shneider graduated from Columbia University College of Physicians and Surgeons in 1994.

Dr. Shneider is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.